...
首页> 外文期刊>World Journal of Gastroenterology >Differential treatment and early outcome in the interventional endoscopic management of pancreatic pseudocysts in 27 patients.
【24h】

Differential treatment and early outcome in the interventional endoscopic management of pancreatic pseudocysts in 27 patients.

机译:27例胰腺假性囊肿的介入内镜处理中的差异治疗和早期结果。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: Pancreatic pseudocysts (PPC) as a complication of pancreatitis are approached only in the case of abdominal pain, infection, bleeding, and compression onto the gastrointestinal tract or biliary tree. METHODS: From 02/01/2002 to 05/31/2004, all consecutive patients with symptomatic PPC who underwent an interventional endoscopic approach were evaluated in this pilot case-series study: Group (Gr.) I-Primary percutaneous (external), ultrasound-guided drainage. Gr. II-Primary EUS-guided cystogastrostomy. Gr. III-EUS-guided cystogastrostomy including intracystic necrosectomy. RESULTS: (="follow up": n = 27): Gr. I (n = 9; 33.3%): No complaints (n = 3); change of an external into an internal drainage (n = 4); complications: (a) bleeding (n = 1) followed by 3 d at ICU, discharge after 40 d; (b) septic shock (n = 1) followed by ICU and several laparotomies for programmed lavage and necrosectomy, death after 74 d. Gr. II (n = 13; 48.1%): No complaints (n = 11); external drainage (n = 2); complications/problems out of the 13 cases: 2nd separate pseudocyst (n = 1) with external drainage (since no communication with primary internal drainage); infection of the residual cyst (n = 1) + following external drainage; spontaneous PPC perforation (n = 1) + following closure of the opening of the cystogastrostomy using clips and subsequently ICU for 2 d. Gr. III (n = 5; 18.5%): No complaints in all patients, in average two endoscopic procedures required (range, 2-6). CONCLUSION: Interventional endoscopic management of pancreatic pseudocysts is a reasonable alternative treatment option with low invasiveness compared to surgery and an acceptable outcome with regard to the complication rate (11.1%) and mortality (3.7%), as shown by these initial study results.
机译:目的:胰腺假性囊肿(PPC)是胰腺炎的并发症,仅在腹痛,感染,出血和压迫胃肠道或胆道树的情况下才可使用。方法:从2002年2月1日至2004年5月31日,在该试验性病例系列研究中评估了所有接受过内镜介入治疗的连续性有症状PPC患者:组(Gr。)I-主要经皮(外部),超声引导引流。 Gr。 II级EUS引导的膀胱造口术。 Gr。 III-EUS引导的膀胱造口术,包括囊内坏死切除术。结果:(=“ follow up”:n = 27):Gr。 I(n = 9; 33.3%):无投诉(n = 3);将外部排水改为内部排水(n = 4);并发症:(a)出血(n = 1),随后在ICU 3 d,40 d后出院; (b)败血性休克(n = 1),然后进行重症监护病房(ICU)和多次开腹手术,以进行程序性灌洗和坏死切除,术后74 d死亡。 Gr。 II(n = 13; 48.1%):无投诉(n = 11);外部排水(n = 2); 13例中的并发症/问题:第二个单独的假性囊肿(n = 1),有外部引流(因为与原发内部引流无联系);外部引流后残留囊肿的感染(n = 1)+;自发性PPC穿孔(n = 1)+使用夹子闭合膀胱造口术开口后,随后ICU进行2 d。 Gr。 III(n = 5; 18.5%):所有患者均无不适,平均需要两次内窥镜检查(范围2-6)。结论:胰腺假性囊肿的介入内镜处理是一种合理的替代治疗选择,与手术相比具有较低的侵袭性,并且在并发症发生率(11.1%)和死亡率(3.7%)方面都可以接受,如这些初步研究结果所示。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号